SlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Healthcare Transition Outcomes in Adolescents and Young Adults Living with Perinatal HIV in Thailand - L. AurpibulView Slideset
TSTavitiya SudjaritrukMD, ScM, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Growth Recovery Among Asian Children with Perinatally Acquired HIV Infection on First-line Combination Antiretroviral Therapy - T. Sudjaritruk, MD, ScM, PhDView Slideset
WNSWipaporn Natalie SongtaweesinMBBS, DTMHSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Collaborative Care Model to Facilitate Integration of Mental Healthcare into HIV Treatment and Prevention Services for Adolescents and Young Adults in Bangkok, Thailand - W. N. Songtaweesin, MBBS, DTMHView Slideset
SLSharon LewinAO, FRACP, PhD, FAHMSSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Effectively Communicating Your Research Objectives in Grant ApplicationsView Slideset
SLSharon LewinAO, FRACP, PhD, FAHMSSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Update on COVID-19 Vaccines - What’s Available and What's the Future S. Lewin, AO, FRACP, PhD, FAHMSView Slideset
YJLYing-Ru Jacqueline LoMDSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021The COVAX Facility - Fair and Equitable Access to COVID-19 Vaccines - Y. Lo, MDView Slideset
NPNittaya PhanuphakMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Translating the Science of Long-acting PrEP into Implementation - N. Phanuphak, MD, PhDView Slideset
RMGRoy M. GulickMD, MPHSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Positioning Long-acting ARV in LMIC - R. Gulick, MD, MPHView Slideset
RMGRoy M. GulickMD, MPHSlidesetHIVRSVViral Hepatitis and Liver DiseaseTuberculosisAPACC 2021Positioning Long-acting ARV in LMIC - R. Gulick, MD, MPHView Slideset
WSWai-Kay SetoMBBS, MD, MRCP, FRCP, FHKCP, FHKAM, AGAFSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Prevention and Monitoring Strategies for HCC in HBV Patients - W. Seto, MBBS, MD, MRCP, FRCP, FHKCP, FHKAM, AGAFView Slideset
MPMassimo PuotiMDSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Management of HCC - M. Puoti, MDView Slideset
LWLinfa WangPhD, FTSESlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Virology of SARS-CoV-2 - L. Wang, PhD, FTSEView Slideset
